Improvement of hepatic lipid peroxidation in patients with chronic hepatitis C after iron reduction therapy.

被引：0
|
作者：
Kobayashi, Y
Kawamura, K
Hayashi, H
Yano, M
Yoshioka, K
Nakamura, H
机构：
[1] Hamamatsu Univ Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka 43131, Japan
[2] Hokuriku Univ, Dept Med, Kanazawa, Ishikawa, Japan
[3] Nagoya Univ, Sch Med, Dept Internal Med 3, Nagoya, Aichi 466, Japan
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1696
引用
收藏
页码：587A / 587A
页数：1
相关论文
共 50 条
  • [1] Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C
    Kaito, Masahiko
    Iwasa, Motoh
    Kobayashi, Yoshinao
    Fujita, Naoki
    Tanaka, Hideaki
    Gabazza, Esteban C.
    Adachi, Yukihiko
    Kojima, Yuji
    Nakagawa, Naoki
    Watanabe, Shozo
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (09) : 921 - 922
  • [2] Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C
    Masahiko Kaito
    Motoh Iwasa
    Yoshinao Kobayashi
    Naoki Fujita
    Hideaki Tanaka
    Esteban C. Gabazza
    Yukihiko Adachi
    Yuji Kojima
    Naoki Nakagawa
    Shozo Watanabe
    Journal of Gastroenterology, 2006, 41 : 921 - 922
  • [3] Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C
    Kageyama, F
    Kobayashi, Y
    Kawasaki, T
    Toyokuni, S
    Uchida, K
    Nakamura, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (04): : 1041 - 1050
  • [4] Improvement in hepatic lipid peroxidation in patients with complete response to interferon-α treatment for chronic hepatitis C.
    Kageyama, F
    Kobayashi, Y
    Kawasaki, T
    Toyokuni, S
    Uchida, K
    Nakamura, H
    HEPATOLOGY, 1998, 28 (04) : 250A - 250A
  • [5] HEPATIC LIPID-PEROXIDATION IN CHRONIC HEPATITIS-C
    KIKUYAMA, M
    KOBAYASHI, Y
    KAWASAKI, T
    YOSHIMI, T
    HEPATOLOGY, 1995, 22 (04) : 678 - 678
  • [6] Enhanced hepatic lipid peroxidation in chronic hepatitis C.
    Kageyama, F
    Kobayashi, Y
    Kawasaki, T
    Nakamura, H
    Toyokuni, S
    Uchida, K
    HEPATOLOGY, 1997, 26 (04) : 79 - 79
  • [7] Improvement of quantitative testing of liver function in patients with chronic hepatitis C after initiation of antiviral therapy.
    Herold, C
    Schneider, HT
    Schuppan, D
    Hahn, EG
    GASTROENTEROLOGY, 2000, 118 (04) : A955 - A955
  • [8] Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C
    Konishi, Masayoshi
    Iwasa, Motoh
    Yamauchi, Koji
    Sugimoto, Ryosuke
    Fujita, Naoki
    Kobayashi, Yoshinao
    Watanabe, Shozo
    Teraguchi, Susumu
    Adachi, Yukihiko
    Kaito, Masahiko
    HEPATOLOGY RESEARCH, 2006, 36 (01) : 27 - 32
  • [9] Lactoferrin inhibits lipid peroxidation in chronic hepatitis C patients
    Iwasa, Motoh
    Kaito, Masahiko
    Yamauchi, Koji
    Sugimoto, Ryosuke
    Yamamoto, Mika
    Nakagawa, Naoki
    Konishi, Masayoshi
    Watanabe, Shozo
    Teraguchi, Susumu
    Adachi, Yukihiko
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2006, 84 (03): : 391 - 391
  • [10] Improvement of liver fibrosis in chronic hepatitis C patients with no response to interferon alpha therapy.
    Yagura, H
    Murai, S
    Kojima, H
    Tokita, H
    Kamitsukasa, H
    Harada, H
    HEPATOLOGY, 1998, 28 (04) : 209A - 209A
12345